Skip to main content
Erschienen in: Journal of Interventional Cardiac Electrophysiology 2/2015

01.08.2015

Use of vascular closure device is safe and effective in electrophysiological procedures

verfasst von: Ilir Maraj, Adam S. Budzikowski, Waleed Ali, Crisitina A. Mitre, John Kassotis

Erschienen in: Journal of Interventional Cardiac Electrophysiology | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Little is known about the usefulness and safety of vascular closure devices (VCDs) in electrophysiological procedures. We present a retrospective analysis of our experience assessing the utility and outcomes of collagen vascular closure device (Angioseal) in patients that required periprocedural anticoagulation and multiple vascular access sites.

Methods

An retrospective chart review of patients who have undergone the deployment of VCD following electrophysiological procedures.

Results

In 26 patients (16 males, age 57 ± 15 years, weight 96 ± 21 kg), a total of 76 VCD were deployed. Seventy-three VCDs in femoral veins (right or left) and three in femoral artery. The mean number of VCD per patient was 3 (range, 2–4). VCD was successfully deployed in 75 out of 76 access sites. One patient was noted to have ecchymosis in both groins during follow-up visit. No other complications were noted.

Conclusions

We provide evidence that a collagen plug-based VCD designed for arterial closure can be safely and effectively used to close multiple venous accesses even in the same vein. This can be accomplished with a venotomy size up to 2 Fr larger than the size of the closure device.
Literatur
1.
Zurück zum Zitat Dangas, G., Mehran, R., Kokolis, S., Feldman, D., Satler, L. F., Pichard, A. D., et al. (2001). Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. Journal of the American College of Cardiology, 38(3), 638–641.PubMedCrossRef Dangas, G., Mehran, R., Kokolis, S., Feldman, D., Satler, L. F., Pichard, A. D., et al. (2001). Vascular complications after percutaneous coronary interventions following hemostasis with manual compression versus arteriotomy closure devices. Journal of the American College of Cardiology, 38(3), 638–641.PubMedCrossRef
2.
Zurück zum Zitat Resnic, F. S., Blake, G. J., Ohno-Machado, L., Selwyn, A. P., Popma, J. J., & Rogers, C. (2001). Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors. American Journal of Cardiology, 88(5), 493–496.PubMedCrossRef Resnic, F. S., Blake, G. J., Ohno-Machado, L., Selwyn, A. P., Popma, J. J., & Rogers, C. (2001). Vascular closure devices and the risk of vascular complications after percutaneous coronary intervention in patients receiving glycoprotein IIb-IIIa inhibitors. American Journal of Cardiology, 88(5), 493–496.PubMedCrossRef
3.
Zurück zum Zitat Coto, H. A. (2002). Closure of the femoral vein puncture site after transcatheter procedures using Angio-Seal. Catheterization and Cardiovascular Interventions, 55(1), 16–19.PubMedCrossRef Coto, H. A. (2002). Closure of the femoral vein puncture site after transcatheter procedures using Angio-Seal. Catheterization and Cardiovascular Interventions, 55(1), 16–19.PubMedCrossRef
4.
Zurück zum Zitat Shaw, J. A., Dewire, E., Nugent, A., & Eisenhauer, A. C. (2004). Use of suture-mediated vascular closure devices for the management of femoral vein access after transcatheter procedures. Catheterization and Cardiovascular Interventions, 63(4), 439–443.PubMedCrossRef Shaw, J. A., Dewire, E., Nugent, A., & Eisenhauer, A. C. (2004). Use of suture-mediated vascular closure devices for the management of femoral vein access after transcatheter procedures. Catheterization and Cardiovascular Interventions, 63(4), 439–443.PubMedCrossRef
5.
Zurück zum Zitat Hamid, T., Rajagopal, R., Pius, C., Clarke, B., & Mahadevan, V. S. (2013). Preclosure of large-sized venous access sites in adults undergoing transcatheter structural interventions. Catheterization and Cardiovascular Interventions, 81(4), 586–590.PubMedCrossRef Hamid, T., Rajagopal, R., Pius, C., Clarke, B., & Mahadevan, V. S. (2013). Preclosure of large-sized venous access sites in adults undergoing transcatheter structural interventions. Catheterization and Cardiovascular Interventions, 81(4), 586–590.PubMedCrossRef
6.
Zurück zum Zitat Srivatsa, S. S., Srivatsa, A., & Spangler, T. A. (2015). Mynx vascular closure device achieves reliable closure and hemostasis of percutaneous transfemoral venous access in a porcine vascular model. Journal of Invasive Cardiology, 27(2), 121–127.PubMed Srivatsa, S. S., Srivatsa, A., & Spangler, T. A. (2015). Mynx vascular closure device achieves reliable closure and hemostasis of percutaneous transfemoral venous access in a porcine vascular model. Journal of Invasive Cardiology, 27(2), 121–127.PubMed
7.
Zurück zum Zitat Bangard, C., Chang, D. H., Libicher, M., Bovenschulte, H., Kochanek, M., Reuter, H., et al. (2013). Misplacement of central venous catheters in the subclavian artery: Safe retrieval with a percutaneous closure device (AngioSeal). Röfo, 185(6), 546–549.PubMed Bangard, C., Chang, D. H., Libicher, M., Bovenschulte, H., Kochanek, M., Reuter, H., et al. (2013). Misplacement of central venous catheters in the subclavian artery: Safe retrieval with a percutaneous closure device (AngioSeal). Röfo, 185(6), 546–549.PubMed
8.
Zurück zum Zitat Mylonas, I., Sakata, Y., Salinger, M., Sanborn, T. A., & Feldman, T. (2006). The use of percutaneous suture-mediated closure for the management of 14 French femoral venous access. Journal of Invasive Cardiology, 18(7), 299–302.PubMed Mylonas, I., Sakata, Y., Salinger, M., Sanborn, T. A., & Feldman, T. (2006). The use of percutaneous suture-mediated closure for the management of 14 French femoral venous access. Journal of Invasive Cardiology, 18(7), 299–302.PubMed
9.
Zurück zum Zitat Chu, Y. Q., Cai, L. J., Jiang, D. C., Jia, D., Yan, S. Y., & Wang, Y. Q. (2010). Allergic shock and death associated with protamine administration in a diabetic patient. Clinical Therapeutics, 32(10), 1729–1732.PubMedCrossRef Chu, Y. Q., Cai, L. J., Jiang, D. C., Jia, D., Yan, S. Y., & Wang, Y. Q. (2010). Allergic shock and death associated with protamine administration in a diabetic patient. Clinical Therapeutics, 32(10), 1729–1732.PubMedCrossRef
10.
Zurück zum Zitat Chilukuri, K., Henrikson, C. A., Dalal, D., Scherr, D., MacPherson, E. C., Cheng, A., et al. (2009). Incidence and outcomes of protamine reactions in patients undergoing catheter ablation of atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 25(3), 175–181.PubMedCrossRef Chilukuri, K., Henrikson, C. A., Dalal, D., Scherr, D., MacPherson, E. C., Cheng, A., et al. (2009). Incidence and outcomes of protamine reactions in patients undergoing catheter ablation of atrial fibrillation. Journal of Interventional Cardiac Electrophysiology, 25(3), 175–181.PubMedCrossRef
Metadaten
Titel
Use of vascular closure device is safe and effective in electrophysiological procedures
verfasst von
Ilir Maraj
Adam S. Budzikowski
Waleed Ali
Crisitina A. Mitre
John Kassotis
Publikationsdatum
01.08.2015
Verlag
Springer US
Erschienen in
Journal of Interventional Cardiac Electrophysiology / Ausgabe 2/2015
Print ISSN: 1383-875X
Elektronische ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-015-0005-5

Weitere Artikel der Ausgabe 2/2015

Journal of Interventional Cardiac Electrophysiology 2/2015 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.